News

According to research conducted by a team led by Dr. Sahar Bedrood of Acuity Eye Group, anti–vascular endothelial growth factor therapy (Anti-VEGF) injections could have a significant impact on the prevalence of ocular hypertension and primary open-angle glaucoma.
February is a time to bring awareness to Age-Related Macular Degeneration (AMD), one of the leading causes of blindness in the United States.
Development allows Acuity Eye Group to expand geographic footprint throughout San Diego region.
Development allows Acuity Eye Group to expand geographic footprint throughout South Bay.
Development allows Acuity Eye Group to expand geographic footprint throughout Orange County.
Development allows Acuity Eye Group to expand geographic footprint throughout San Diego.
Physician-owned and professionally-managed ophthalmology group expands market presence through its unique business model.